The drug was as good as a proven GLP-1, giving doctors another potent option for patients with type 2 diabetes and ...

Columnist Mike Naple would rather be focusing on baking utensils this holiday season, but living with PH requires multiple ...

Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on sleep related breathing disorders, including obstructive sleep ...

Compared with the outpatient setting, there is a lack of guidance on diagnosing, managing and treating obstructive sleep ...

Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective diagnostic procedures and ...

Magnesium aids GABA regulation, acting as a nervous system “brake pedal.” It is an adjuvant, not a replacement, for mechanical therapies like CPAP. Deficiency is widespread in older adults and those ...

Parkinson's disease affects more than 1.1 million people in the U.S. Early treatment of obstructive sleep apnea -- a condition that causes breathing to briefly pause -- may decrease the risk of ...

As the hospitalist workforce grows, sleep medicine experts suggest that hospitals and their patients could benefit from having sleep medicine hospitalists available, too. Doing so will make it so ...

People with both type 2 diabetes (T2D) and obstructive sleep apnoea (OSA) have a higher risk of death, but treatment with continuous positive airway pressure (CPAP) may reduce that risk by around 26%, ...

Hello, and welcome to the Q1 Fiscal Year 2026 ResMed Earnings Conference Call. My name is Kevin. I'll be your operator for today's call. [Operator Instructions] Also, please note, this conference call ...

Obstructive sleep apnoea (OSA) is a prevalent chronic condition that is associated with cardiometabolic and neurocognitive complications. While continuous positive airway pressure (CPAP) remains the ...